|
|
|
|
Fletcher Spaght Ventures, (FSV) is a balanced-stage venture capital firm investing in high growth opportunities in healthcare/life sciences and related information technology companies.
FSV was established in 2001 by Fletcher Spaght, Inc. (FSI), a strategy consulting firm founded in 1983. The FSI:FSV collaboration provides key differentiation from other venture capital firms and allows for significant advantages in deal sourcing and investing:
- FSV leverages the FSI client base and extensive industry and investment relationships built over the past thirty years, to identify and gain access to unique investment opportunities
- FSV capitalizes on FSI’s market intelligence, industry expertise and broad experience in new venture strategy and business planning in assessing the potential for each FSV investment opportunity
- As value-added investors post-investment, the FSV Partners and FSI consulting staff contribute their deep expertise in healthcare/life science and information technology, as well as their general strategic and analytical skills, to enhance the value of FSV portfolio companies
FSV’s healthcare/life science interests include: medical devices, diagnostics, research and development tools, biotechnology, regenerative medicine, healthcare services, and data management solutions and analytics to transform processes, reduce costs and/or improve outcomes.
|
|
|
|
